Two compounds (DB2313 and DB2115) that selectively inhibit PU.1 interaction with DNA85 blocked neutrophil to nAPC conversion in response to Ova, Ova-IC and SLE-IC in vitro without affecting cell survival (Fig. 9b, Supplementary Fig. 14a). This evidence concerns the gene SPI1 and systemic lupus erythematosus.